<DOC>
	<DOCNO>NCT01814761</DOCNO>
	<brief_summary>This study bimatoprost 0.01 % ( LUMIGAN® 0.01 % ) subject primary open-angle glaucoma ( POAG ) ocular hypertension ( OH ) require treatment elevate intraocular pressure ( IOP ) .</brief_summary>
	<brief_title>A Study Bimatoprost 0.01 % Clinical Setting</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Diagnosis primary openangle glaucoma ocular hypertension Determined treat physician require treatment bimatoprost 0.01 % . Previous use Lumigan® 0.01 %</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>